New MIMS table summarises monitoring requirements for lipid-lowering drugs

GPs can now use a handy MIMS table to check which tests are needed for patients taking statins or other hyperlipidaemia treatments.

Patients taking lipid-lowering drugs may need to be monitored for signs of myopathy and rhabdomyolysis.
Patients taking lipid-lowering drugs may need to be monitored for signs of myopathy and rhabdomyolysis.

The new quick-reference table summarises the recommended frequency of testing for creatine kinase, liver and renal function and other parameters in patients taking the following classes of lipid-lowering drugs:

  • Bile acid sequestrants (colesevelam, colestipol, colestyramine)
  • Cholesterol absorption inhibitors (ezetimibe, ezetimibe/simvastatin)
  • Fibrates (bezafibrate, ciprofibrate, fenofibrate, gemfibrozil)
  • Fibrates/statins (fenofibrate/simvastatin)
  • Acipimox (Olbetam)
  • Omega-3 (Omacor, Teromeg)
  • PCSK9 inhibitors (alirocumab, evolocumab)
  • Statins (atorvastatin, fluvastatin, pravastatin, rosuvastatin, simvastatin)

Drug names link through to the full MIMS entries for more detailed prescribing information on each product.

Information is summarised from manufacturers' Summaries of Product Characteristics (SPCs), available at medicines.org.uk.

The new table is also available in the MIMS app, for easy access when at home or on the go.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Gluten-free prescribing restricted to bread and mixes

Gluten-free prescribing restricted to bread and mixes

GPs in England are no longer able to prescribe gluten-free...

New vitamin D deficiency thresholds recommended

New vitamin D deficiency thresholds recommended

The National Osteoporosis Society (NOS) has updated...

SGLT2 inhibitors associated with increased risk of lower-limb amputation in new study

SGLT2 inhibitors associated with increased risk of lower-limb amputation in new study

SGLT2 inhibitors may be linked to a doubling in the...

New MIMS table helps prescribers choose asthma inhalers

New MIMS table helps prescribers choose asthma inhalers

Prescribers can now turn to a handy MIMS comparison...